Myovant Sciences Company
Myovant Sciences is to deliver innovative women's health and prostate cancer solutions by efficiently advancing new medicines to market.
Connections from
Headquarters:
London, England, United Kingdom
Last Funding Type:
Post-IPO Debt
Investors Number:
1
Last Funding Date:
2020-08-05
Employee Number:
101-250
Total Funding:
$200,000,000
Founded Date:
01-01-2016
Estimated Revenue:
$10M to $50M
Industry:
Menstrual Health
Funding Status:
IPO